A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
An open-label, randomised, controlled, multi-centre, trial with disease free survival as the
primary end point. The worldwide collaboration is referred to as GLOBAL BALLAD and consists
of a number of individual parallel prospective studies addressing the same objectives with
similar designs brought together under the framework of the International Rare Cancer
Initiative. This protocol is for BALLAD BELGIUM, which is the component of GLOBAL BALLAD.